TARO-LENALIDOMIDE
TARO-LENALIDOMIDE
Approved
DIN Number
02507862
Drug Class
Human
Market Date
Jun 13, 2022
Company
HC
Taro Pharmaceuticals Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02507862
AIG Number0152422006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AX04 LENALIDOMIDE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
LENALIDOMIDEActive
Strength: 2.5 MG
Monograph: LENALIDOMIDE